Inactive Instrument
Midatech Pharma PLC Stock Nasdaq
Stocks
US59564R1041
Biotechnology & Medical Research
| Market Cap | 535K 709K 623K 585K 1M 67.96M 1.01M 7.03M 2.73M 34.65M 2.66M 2.61M 112M | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 535K 709K 623K 585K 1M 67.96M 1.01M 7.03M 2.73M 34.65M 2.66M 2.61M 112M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
0.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.38% |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Stamp
CEO | Chief Executive Officer | 65 | 31/03/2020 |
Fiona Sharp
DFI | Director of Finance/CFO | 58 | 05/01/2026 |
Noreen Bhatti
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Sijmen de Vries
BRD | Director/Board Member | 67 | 13/11/2014 |
Simon Turton
BRD | Director/Board Member | 59 | 12/12/2014 |
Stephen Stamp
BRD | Director/Board Member | 65 | 09/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.38% | -20.98% | - | - | 709K | |
| +0.06% | +6.49% | +60.29% | +111.13% | 74.18B | |
| -0.22% | -3.89% | +34.12% | +74.81% | 59.55B | |
| -2.05% | -3.46% | -18.60% | +352.20% | 25.84B | |
| -2.39% | +2.74% | +0.19% | -5.91% | 24.73B | |
| -0.57% | +1.52% | +21.98% | -9.64% | 20.87B | |
| +1.29% | -2.49% | +152.11% | +333.06% | 15.32B | |
| -2.44% | -0.09% | +42.50% | +164.11% | 14.06B | |
| -3.91% | -4.91% | -14.10% | +779.68% | 13.12B | |
| -1.12% | -3.04% | +15.72% | +234.56% | 11.85B | |
| Average | -0.64% | -0.40% | +32.69% | +226.00% | 28.84B | |
| Weighted average by Cap. | -0.56% | +0.70% | +36.28% | +161.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
